JP2017538446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538446A5 JP2017538446A5 JP2017547931A JP2017547931A JP2017538446A5 JP 2017538446 A5 JP2017538446 A5 JP 2017538446A5 JP 2017547931 A JP2017547931 A JP 2017547931A JP 2017547931 A JP2017547931 A JP 2017547931A JP 2017538446 A5 JP2017538446 A5 JP 2017538446A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant protein
- perfusion
- mammalian host
- bioreactor
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462085759P | 2014-12-01 | 2014-12-01 | |
| US62/085,759 | 2014-12-01 | ||
| PCT/US2015/063271 WO2016089919A1 (en) | 2014-12-01 | 2015-12-01 | Process for manipulating the level of glycan content of a glycoprotein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020080270A Division JP7066775B2 (ja) | 2014-12-01 | 2020-04-30 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538446A JP2017538446A (ja) | 2017-12-28 |
| JP2017538446A5 true JP2017538446A5 (enExample) | 2019-01-17 |
| JP6698681B2 JP6698681B2 (ja) | 2020-05-27 |
Family
ID=55024253
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017547931A Active JP6698681B2 (ja) | 2014-12-01 | 2015-12-01 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
| JP2020080270A Active JP7066775B2 (ja) | 2014-12-01 | 2020-04-30 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
| JP2022072126A Pending JP2022101669A (ja) | 2014-12-01 | 2022-04-26 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
| JP2024063188A Pending JP2024095777A (ja) | 2014-12-01 | 2024-04-10 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020080270A Active JP7066775B2 (ja) | 2014-12-01 | 2020-04-30 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
| JP2022072126A Pending JP2022101669A (ja) | 2014-12-01 | 2022-04-26 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
| JP2024063188A Pending JP2024095777A (ja) | 2014-12-01 | 2024-04-10 | 糖タンパク質のグリカン含量のレベルを操作するためのプロセス |
Country Status (22)
| Country | Link |
|---|---|
| US (6) | US10167492B2 (enExample) |
| EP (2) | EP3680344A1 (enExample) |
| JP (4) | JP6698681B2 (enExample) |
| KR (1) | KR102623965B1 (enExample) |
| CN (1) | CN107109455B (enExample) |
| AU (5) | AU2015355087C1 (enExample) |
| CA (1) | CA2969225C (enExample) |
| CL (1) | CL2017001369A1 (enExample) |
| CY (1) | CY1123247T1 (enExample) |
| DK (1) | DK3227454T3 (enExample) |
| EA (2) | EA036178B1 (enExample) |
| ES (1) | ES2784503T3 (enExample) |
| HU (1) | HUE049201T2 (enExample) |
| IL (2) | IL276165B (enExample) |
| LT (1) | LT3227454T (enExample) |
| MX (1) | MX385409B (enExample) |
| PL (1) | PL3227454T3 (enExample) |
| PT (1) | PT3227454T (enExample) |
| SG (2) | SG10202002458PA (enExample) |
| SI (1) | SI3227454T1 (enExample) |
| WO (1) | WO2016089919A1 (enExample) |
| ZA (2) | ZA201703729B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2969225C (en) | 2014-12-01 | 2023-08-22 | Amgen Inc. | Process for manipulating the level of glycan content of a glycoprotein |
| EP4310503A3 (en) | 2015-12-30 | 2024-03-20 | Momenta Pharmaceuticals, Inc. | Methods related to biologics |
| AU2018235928B2 (en) | 2017-03-14 | 2023-09-21 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| WO2018178069A1 (en) * | 2017-03-31 | 2018-10-04 | Boehringer Ingelheim International Gmbh | Perfusion medium |
| WO2019105444A1 (zh) * | 2017-11-30 | 2019-06-06 | 正大天晴药业集团南京顺欣制药有限公司 | 蛋白质的生产方法 |
| US12325737B2 (en) * | 2018-03-26 | 2025-06-10 | Amgen Inc. | Total afucosylated glycoforms of antibodies produced in cell culture |
| US20210147532A1 (en) * | 2018-05-24 | 2021-05-20 | Ares Trading S.A. | Method for controlling the afucosylation level of a glycoprotein composition |
| MA52783A (fr) | 2018-06-05 | 2021-04-14 | Amgen Inc | Modulation de la phagocytose cellulaire dépendant de l'anticorps |
| CN113286650A (zh) | 2018-09-06 | 2021-08-20 | 动量制药公司 | 连续细胞培养方法 |
| EP3850006A1 (en) | 2018-09-11 | 2021-07-21 | Amgen Inc. | Methods of modulating antibody-dependent cell-mediated cytotoxicity |
| HU231514B1 (hu) * | 2018-11-07 | 2024-07-28 | Richter Gedeon Nyrt. | Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer |
| CN113015805B (zh) | 2018-11-13 | 2024-12-03 | 詹森生物科技公司 | 抗cd38抗体产生期间的痕量金属的控制 |
| KR20210131323A (ko) | 2018-12-31 | 2021-11-02 | 모멘타 파머슈티컬스 인코포레이티드 | 우스테키누맙 생성 방법 |
| MX2021008983A (es) * | 2019-01-30 | 2021-09-08 | Amgen Inc | Atributos de aflibercept y metodos de caracterizacion y modificacion de los mismos. |
| CN114144434A (zh) | 2019-05-06 | 2022-03-04 | 美国安进公司 | 调节抗体效应子功能 |
| JP2020188737A (ja) * | 2019-05-23 | 2020-11-26 | 東ソー株式会社 | 抗体依存性細胞傷害活性が向上した抗体の製造方法 |
| KR20220069982A (ko) | 2019-09-26 | 2022-05-27 | 암젠 인크 | 항체 조성물의 생산 방법 |
| WO2021097281A1 (en) | 2019-11-15 | 2021-05-20 | Lonza Ltd | Process and system for producing an inoculum |
| US20230287335A1 (en) * | 2020-07-30 | 2023-09-14 | Amgen Inc. | Cell culture media and methods of making and using the same |
| EP4196597A2 (en) * | 2020-08-14 | 2023-06-21 | Bristol-Myers Squibb Company | Manufacturing process for protein |
| US20240043501A1 (en) | 2020-10-15 | 2024-02-08 | Amgen Inc. | Relative unpaired glycans in antibody production methods |
| AU2022289365A1 (en) | 2021-06-07 | 2023-12-14 | Amgen Inc. | Using fucosidase to control afucosylation level of glycosylated proteins |
| US20230038355A1 (en) * | 2021-07-09 | 2023-02-09 | Janssen Biotech, Inc. | Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions |
| IL309996A (en) * | 2021-07-09 | 2024-03-01 | Janssen Biotech Inc | Production methods for the production of anti-TNF antibody compositions |
| CA3251442A1 (en) | 2022-02-25 | 2023-08-31 | Kashiv Biosciences, Llc | METHOD FOR IMPROVING POLYPEPTIDE EXPRESSION IN A MAMMALIAN CELL CULTURE |
| JP2026516670A (ja) | 2023-04-20 | 2026-05-26 | アムジエン・インコーポレーテツド | 相対的な不対グリカン含有量を決定する方法 |
| EP4762088A1 (en) * | 2023-08-16 | 2026-06-24 | Glaxosmithkline Intellectual Property Limited | Method of controlling antibody glycosylation profile |
| WO2026090253A1 (en) | 2024-10-23 | 2026-04-30 | Amgen Inc. | Methods of determining glycan pairing content |
| WO2026099463A1 (en) * | 2024-11-08 | 2026-05-15 | Novartis Ag | Glycoengineered anti-cd20 antibodies |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| AU588819B2 (en) | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
| US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
| DE59010908D1 (de) | 1989-09-12 | 2000-08-10 | Hoffmann La Roche | TNF-bindende Proteine |
| US6204363B1 (en) | 1989-10-16 | 2001-03-20 | Amgen Inc. | Stem cell factor |
| US5272064A (en) | 1989-12-19 | 1993-12-21 | Amgen Inc. | DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
| US5149792A (en) | 1989-12-19 | 1992-09-22 | Amgen Inc. | Platelet-derived growth factor B chain analogs |
| US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
| WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
| US5096816A (en) | 1990-06-05 | 1992-03-17 | Cetus Corporation | In vitro management of ammonia's effect on glycosylation of cell products through pH control |
| US6284471B1 (en) * | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| PT672141E (pt) | 1992-10-23 | 2003-09-30 | Immunex Corp | Metodos de preparacao de proteinas oligomericas soluveis |
| US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
| US5981713A (en) | 1994-10-13 | 1999-11-09 | Applied Research Systems Ars Holding N.V. | Antibodies to intereleukin-1 antagonists |
| US5721121A (en) | 1995-06-06 | 1998-02-24 | Genentech, Inc. | Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
| CA2225378C (en) | 1995-06-29 | 2012-04-17 | Immunex Corporation | Cytokine that induces apoptosis |
| US6613544B1 (en) | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
| US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US6337072B1 (en) | 1998-04-03 | 2002-01-08 | Hyseq, Inc. | Interleukin-1 receptor antagonist and recombinant production thereof |
| US6528286B1 (en) | 1998-05-29 | 2003-03-04 | Genentech, Inc. | Mammalian cell culture process for producing glycoproteins |
| JP2001120262A (ja) * | 1999-10-26 | 2001-05-08 | Welfide Corp | 生理活性物質の産生増強方法 |
| AU1920301A (en) | 1999-11-17 | 2001-05-30 | Immunex Corporation | Receptor activator of nf-kappa b |
| US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
| TWI314933B (en) | 2000-05-26 | 2009-09-21 | Bristol Myers Squibb Compan | Soluble ctla4 mutant molecules and uses thereof |
| EP1498491A4 (en) | 2002-04-09 | 2006-12-13 | Kyowa Hakko Kogyo Kk | METHOD FOR INCREASING THE ACTIVITY OF AN ANTIBODY COMPOSITION FOR BINDING TO THE FC GAMMA RECEPTOR IIIA |
| DE10312765A1 (de) | 2003-03-21 | 2004-09-30 | Bayer Technology Services Gmbh | Vorrichtung und Verfahren zur Sterilisation flüssiger Medien mittels UV-Bestrahlung und Kurzzeiterhitzung |
| US7294484B2 (en) | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
| US7300773B2 (en) * | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
| US8053238B2 (en) | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
| US20070231895A1 (en) | 2005-11-02 | 2007-10-04 | Lee Gene W | Methods for adapting mammalian cells |
| EP3026109B1 (en) | 2005-12-08 | 2022-03-09 | Amgen Inc. | Improved production of glycoproteins using manganese |
| WO2007081031A1 (ja) * | 2006-01-16 | 2007-07-19 | Hokkaido University | 糖転移酵素阻害剤 |
| DK2041270T3 (da) | 2006-07-13 | 2014-01-27 | Wyeth Llc | Fremstilling af glycoproteiner |
| WO2008008482A2 (en) * | 2006-07-13 | 2008-01-17 | Genentech, Inc. | Altered br3-binding polypeptides |
| FR2904558B1 (fr) * | 2006-08-01 | 2008-10-17 | Lab Francais Du Fractionnement | "composition de facteur vii recombinant ou transgenique, presentant majoritairement des formes glycanniques biantennees, bisialylees et non fucosylees" |
| MX2009004519A (es) | 2006-11-03 | 2009-05-12 | Wyeth Corp | Sustancias que inhiben la glucolisis en un cultivo de celulas. |
| CA2679941C (en) | 2007-03-02 | 2016-09-20 | Wyeth | Use of copper and glutamate in cell culture for production of polypeptides |
| EP2137320A4 (en) * | 2007-03-30 | 2010-06-16 | Centocor Ortho Biotech Inc | HIGH-EXPRESSION CLONES OF MAMMALIAN CELLS WITH A FLUORESCENT PROTEIN A OR G |
| AU2008240080A1 (en) | 2007-04-16 | 2008-10-23 | Momenta Pharmaceuticals, Inc. | Defined glycoprotein products and related methods |
| US20100221823A1 (en) | 2007-06-11 | 2010-09-02 | Amgen Inc. | Method for culturing mammalian cells to improve recombinant protein production |
| WO2008157247A1 (en) | 2007-06-15 | 2008-12-24 | Amgen Inc. | Methods of treating cell culture media for use in a bioreactor |
| WO2010141855A1 (en) | 2009-06-05 | 2010-12-09 | Momenta Pharmaceuticals, Inc. | Methods of modulating fucosylation of glycoproteins |
| KR20140032944A (ko) | 2010-10-20 | 2014-03-17 | 모르포테크, 인크. | 항폴레이트 수용체 알파 항체 당형태 |
| EP2678423A1 (en) | 2011-02-23 | 2014-01-01 | Amgen Inc. | Cell culture media for uvc exposure and methods related thereto |
| CN103597073B (zh) * | 2011-03-06 | 2019-06-07 | 默克雪兰诺有限公司 | 低岩藻糖细胞系及其应用 |
| US9133493B2 (en) | 2011-04-21 | 2015-09-15 | Amgen Inc. | Method for culturing mammalian cells to improve recombinant protein production |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| SI2726600T1 (sl) | 2011-07-01 | 2017-07-31 | Amgen Inc. | Sesalska celična kultura |
| AR087433A1 (es) * | 2011-08-08 | 2014-03-26 | Merck Sharp & Dohme | Analogos de insulina n-glicosilados |
| BR112014008303A2 (pt) | 2011-09-16 | 2017-04-11 | Amgen Inc | alimentação contínua controlada pré-programada sem feedback de culturas celulares |
| AU2012328753A1 (en) | 2011-10-26 | 2014-04-24 | Amgen Inc. | Methods of reducing or eliminating protein modification and degradation arising from exposure to UV light |
| US20150119558A1 (en) * | 2012-01-20 | 2015-04-30 | Agency For Science, Technology And Research | Cho-gmt recombinant protein expression |
| WO2013114164A1 (en) * | 2012-01-30 | 2013-08-08 | Dr. Reddy's Laboratories Limited | Method for obtaining glycoprotein composition with increased afucosylation content |
| EP2809773B1 (en) * | 2012-01-30 | 2020-09-02 | Dr. Reddy's Laboratories Limited | Process of modulating man5 and/or afucosylation content of glycoprotein composition |
| WO2013138159A1 (en) | 2012-03-15 | 2013-09-19 | Amgen Inc. | Methods of determining exposure to uv light |
| US10481164B2 (en) | 2012-03-26 | 2019-11-19 | Amgen Inc. | Method for using light scattering in real time to directly monitor and control impurity removal in purification processes |
| WO2014054804A1 (ja) * | 2012-10-05 | 2014-04-10 | 協和発酵キリン株式会社 | ヘテロダイマータンパク質組成物 |
| US9677105B2 (en) | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| JP6480926B2 (ja) | 2013-07-23 | 2019-03-13 | バイオコン・リミテッド | タンパク質におけるフコシル化レベルを制御するための方法 |
| RS59881B1 (sr) * | 2014-02-27 | 2020-03-31 | Hoffmann La Roche | Modulacija ćelijskog rasta i glikozilacije u rekombinantnoj proizvodnji glikoproteina |
| EP3215604A4 (en) * | 2014-10-27 | 2018-07-25 | Agency For Science, Technology And Research | Methods of recombinant protein expression in a cell comprising reduced udp-galactose transporter activity |
| CA2969225C (en) | 2014-12-01 | 2023-08-22 | Amgen Inc. | Process for manipulating the level of glycan content of a glycoprotein |
-
2015
- 2015-12-01 CA CA2969225A patent/CA2969225C/en active Active
- 2015-12-01 EP EP20154019.2A patent/EP3680344A1/en active Pending
- 2015-12-01 JP JP2017547931A patent/JP6698681B2/ja active Active
- 2015-12-01 US US15/529,950 patent/US10167492B2/en active Active
- 2015-12-01 ES ES15816598T patent/ES2784503T3/es active Active
- 2015-12-01 HU HUE15816598A patent/HUE049201T2/hu unknown
- 2015-12-01 MX MX2017006997A patent/MX385409B/es unknown
- 2015-12-01 PL PL15816598T patent/PL3227454T3/pl unknown
- 2015-12-01 EA EA201791223A patent/EA036178B1/ru not_active IP Right Cessation
- 2015-12-01 SG SG10202002458PA patent/SG10202002458PA/en unknown
- 2015-12-01 IL IL276165A patent/IL276165B/en unknown
- 2015-12-01 DK DK15816598.5T patent/DK3227454T3/da active
- 2015-12-01 SG SG11201704351WA patent/SG11201704351WA/en unknown
- 2015-12-01 EA EA202091598A patent/EA202091598A3/ru unknown
- 2015-12-01 AU AU2015355087A patent/AU2015355087C1/en active Active
- 2015-12-01 EP EP15816598.5A patent/EP3227454B1/en not_active Revoked
- 2015-12-01 WO PCT/US2015/063271 patent/WO2016089919A1/en not_active Ceased
- 2015-12-01 LT LTEP15816598.5T patent/LT3227454T/lt unknown
- 2015-12-01 KR KR1020177016893A patent/KR102623965B1/ko active Active
- 2015-12-01 PT PT158165985T patent/PT3227454T/pt unknown
- 2015-12-01 CN CN201580071982.6A patent/CN107109455B/zh active Active
- 2015-12-01 SI SI201531140T patent/SI3227454T1/sl unknown
-
2017
- 2017-05-29 IL IL252569A patent/IL252569B/en active IP Right Grant
- 2017-05-29 CL CL2017001369A patent/CL2017001369A1/es unknown
- 2017-05-31 ZA ZA2017/03729A patent/ZA201703729B/en unknown
-
2018
- 2018-11-14 US US16/191,352 patent/US20190085370A1/en not_active Abandoned
-
2020
- 2020-02-05 US US16/783,117 patent/US10822630B2/en active Active
- 2020-03-31 AU AU2020202302A patent/AU2020202302A1/en not_active Abandoned
- 2020-04-07 CY CY20201100325T patent/CY1123247T1/el unknown
- 2020-04-30 JP JP2020080270A patent/JP7066775B2/ja active Active
- 2020-09-29 ZA ZA2020/06002A patent/ZA202006002B/en unknown
- 2020-10-02 US US17/062,199 patent/US20210017565A1/en not_active Abandoned
-
2022
- 2022-01-28 AU AU2022200586A patent/AU2022200586A1/en not_active Abandoned
- 2022-04-26 JP JP2022072126A patent/JP2022101669A/ja active Pending
-
2023
- 2023-01-18 US US18/156,025 patent/US20230159974A1/en not_active Abandoned
-
2024
- 2024-04-10 JP JP2024063188A patent/JP2024095777A/ja active Pending
- 2024-06-24 AU AU2024204313A patent/AU2024204313A1/en not_active Abandoned
-
2025
- 2025-09-01 AU AU2025223948A patent/AU2025223948A1/en active Pending
- 2025-10-22 US US19/365,891 patent/US20260110013A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL310968B1 (en) | Mammalian cell culture | |
| Matanguihan et al. | Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing | |
| RU2009139054A (ru) | ПРИМЕНЕНИЕ НИЗКОЙ ТЕМПЕРАТУРЫ И/ИЛИ НИЗКОГО pН В КУЛЬТУРЕ КЛЕТОК | |
| JP2011521660A5 (enExample) | ||
| JP2019514411A5 (enExample) | ||
| JP2017501749A5 (enExample) | ||
| RU2013152982A (ru) | Способ снижения гетерогенности антител и способ получения соответствующих антител | |
| CN116083344A (zh) | 对连续流动搅拌釜反应器细胞培养系统的连接灌注 | |
| CN102154189B (zh) | 一种rhG-CSF重组工程菌的发酵培养方法 | |
| JP2017505620A5 (enExample) | ||
| CN103320390A (zh) | 一种大规模哺乳动物工程细胞培养方法 | |
| JP2010110331A5 (enExample) | ||
| SI2904092T1 (en) | Ingredients and procedures for the production of glycoproteins | |
| JP2015532096A5 (enExample) | ||
| TW202328427A (zh) | 超高密度細胞儲存方法 | |
| JP2012519485A5 (enExample) | ||
| JP2019500876A5 (enExample) | ||
| CN103773741A (zh) | 笼式通气搅拌生物反应器制备流感疫苗的方法 | |
| IL313983A (en) | Fully fucose-free glycoforms of antibodies are produced in cell culture | |
| CN106222129A (zh) | 一种提高抗体纯度的细胞培养基和培养方法 | |
| CN114127260A (zh) | 高密度连续接种的细胞培养方法及其应用 | |
| KR20200128108A (ko) | 생물 대분자 업스트림 단계별 차단의 생산 방법, 생산 모듈 및 생산에서의 응용 | |
| CN104206173B (zh) | 一种利用野生猴头菇袋料栽培的方法 | |
| CN107299078A (zh) | 一株适应全悬浮培养的猫肾细胞系f‑81 s及其应用 | |
| CN102382794A (zh) | 一种哺乳动物细胞的灌流培养方法 |